CD47 and cancer: Signal regulatory protein alpha (SIRPα) and CD47 have an important role during cancer progression (33) and blocking CD47-SIRPα interaction has been shown to promote the destruction of cancer cells by phagocytes, macrophages, and neutrophils (33).